期刊文献+

MiR-30c通过靶向KRAS抑制肝癌细胞系生长侵袭能力的体外研究 被引量:7

Mi R-30c inhibits proliferative and invasive abilities of human hepatocellular carcinoma cell line in vitro through KRAS signaling pathway
下载PDF
导出
摘要 目的探讨Mi R-30c对肝癌细胞生长和侵袭的影响。方法采用脂质体Lipofectamine 2000将Mi R-30c模拟物组和Mi R-30c模拟物组阴性对照转染至肝癌细胞Huh7,q RT-PCR检测转染效果,细胞免疫荧光、Western blot检测转染后目的蛋白的表达,Transwell、划痕实验检测细胞迁移侵袭能力、MTT法检测细胞增殖活性,流式细胞术检测细胞周期分布的改变。结果成功构建稳定过表达Mi R-30c的肝癌细胞亚系Huh7-Mi R30c,荧光定量PCR结果显示Mi R-30c表达量明显上调,过表达Mi R-30c后Huh7细胞的侵袭和增殖能力均受到明显抑制;抑制Mi R-30c能明显抑制KRAS蛋白和减低p-ERK蛋白表达水平,对ERK蛋白水平无明显影响。结论抑制Mi R-30c表达可能通过调控RAS/MAPK/ERK通路抑制肝癌细胞Huh7增殖和侵袭。 [Objective]To investigate the effects of miR-30 c on the growth and invasion of hepatocellular carcinoma cells.[Methods]Mi R-30 c mimics and miR-30 c mimic negative control were transfected into human hepatocellular carcinoma cell line Huh7 by Lipofectamine 2000. The transfection efficiency was detected by real-time PCR. The target protein was detected by Western blot. Finally, scratch test, transwell cell invasion, MTT and flow cytometry were used to detect the migratory, invasive and proliferative activities of the tumor cells.[Results]A cell subclone stably overexpressing miR-30 c was obtained and verified by real-time quantitative PCR. Mi R-30 c overexpression significantly inhibited the invasion and proliferation of Huh7 cells. Inhibition of miR-30 c did not affect the expression of total ERK, whereas the phosphorylated ERK level was markedly down-regulated and the KRAS protein expression was down-regulated.[Conclusions]Overexpression of miR-30 c could inhibit the migration and proliferation of human hepatocellular carcinoma cell line Huh7 via the RAS/MAPK/ERK pathway.
出处 《中国现代医学杂志》 CAS 北大核心 2015年第12期25-29,共5页 China Journal of Modern Medicine
关键词 MiR-30c KRAS 肝癌 侵袭 增殖 miR-30c KRAS hepatocellular carcinoma invasion proliferation
  • 相关文献

参考文献13

  • 1GIANPIERO DI LEVA, CARLO M CROCE. miRNA profiling of cancer[J]. Current Opinion in Genetics & Development, 2013, 23 (1): 3-11.
  • 2HUANG J, YAO X, ZHANG J, et al. Hypoxia-induced downreg- ulation of MiR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma[J]. Cancer Science, 2013, 104(19): 1609-1617.
  • 3MU YP, SU XL. Polymorphism in pre-MiR-30c contributes to gastric cancer risk in a Chinese population[J]. Med Oncol, 2012, 29(3): 1723-1732.
  • 4DARINA KACHAKOVA, ATANASKA MITKOVA, ELENKO POPOV, et al. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, MiR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer[J]. DNA and Cell Biology, 2012, 138(4): 611-619.
  • 5JIWEI HUANG, XIAOYING YAO, JIN ZHANG, et al. Hypoxi- a-induced downregulation of MiR-30c promotes epithelial-mes- enchymal transition in human renal cell carcinoma[J]. Cancer Science, 2013, 104(12): 1609-1617.
  • 6XIA Y, CHEN Q, ZHONG Z, et al. Down-reg ulation of MiR-30c promotes the invasion of non-small cell lung cancer by targeting MTAI[J]. Cell Physiol Biochem, 32(2): 476-485.
  • 7MILJANA TANIC, KIRA YANOWSKY, CRISTINA RO- DRIGUEZ-ANTONA, et al. Deregulated miRNAs in hereditary breast cancer revealed a role for MiR-30c in regulating KRAS oncogene[J]. PloS One, 2012, 7(6): e38847.
  • 8GONG J, LIU R, ZHUANG R, et al. MiR-30c-1* promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1 [J]. Cancer Science, 2012, 103(11): 645-652.
  • 9ZHONG Z, XIA Y, WANG P, et al. Low expression of microR- NA-30c promotes invasion by inducing epithelial mesenchymal transition in non-small cell lung cancer[J]. Molecular Medicine Reports, 2014, 14(5): 2575-2579.
  • 10RODRIGUEZ-GONZALEZ FG, SIEUWERTS AM, SMID M, et al. MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer[J]. Breast Cancer Res Treat, 2011, 127(1): 43-51.

同被引文献64

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部